Cromolyn Sodium Concentrate Shortage: FDA Update
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Cromolyn Sodium Concentrate is currently in shortage according to the FDA, affecting its availability for pulmonary and allergy treatments, though one manufacturer reports it as available.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Cromolyn Sodium Concentrate.
Cromolyn Sodium Concentrate Shortage
What's in Shortage
The drug in shortage is Cromolyn Sodium Concentrate, with the brand name CROMOLYN SODIUM. It is available in concentrate dosage form and is currently in shortage status. This medication falls under the therapeutic category of Pulmonary/Allergy. The shortage was first posted on 11/03/2023 and last updated on 04/01/2026.
Which Manufacturers Are Affected
Micro Labs LTD is the manufacturer affected, and it reports the drug as available. Their presentation is Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 42571-132-52). Contact information for Micro Labs LTD is (908) 484-7410.
Why There's a Shortage
No specific reason for the shortage was provided in the source data.
What Patients Should Do
Patients who rely on this medication should speak with their pharmacist to check current availability. They can also contact the manufacturer directly for more information. Remember, patients should consult their healthcare provider for any guidance on their treatment; this article does not provide medical advice.
Source
This information is from the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,152 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 8, 2026.
Frequently Asked Questions
Common questions about this FDA drug-shortage notice.